OrbusNeich Unveils New Logistics Center: Capacity Takes a Leap
OrbusNeich Medical Group Holdings Limited, renowned for its pioneering work in interventional devices, has just opened a cutting-edge logistics center in Europe. This facility is crafted to address the growing needs for storage and logistical support, showcasing OrbusNeich's dedication to quality service and outstanding operational performance.
Improving Logistics for Enhanced Service
Spanning 1,200 square meters, the new logistics center represents a substantial boost to OrbusNeich's operational scope. It's designed to store more than 200,000 temperature-sensitive finished products. This significant investment not only meets present requirements but also paves the way for future expansion.
Focus on Sustainability and Efficiency
Mr. David Chien, the Chairman and CEO of OrbusNeich, noted that the investment in this logistics center aligns with their long-term strategy to optimize the supply chain. The facility is equipped with state-of-the-art technologies, such as digital temperature monitoring systems, ensuring that operations remain both efficient and environmentally responsible.
Strategic Steps After Acquisition
In the wake of acquiring eucatech AG, OrbusNeich has broadened its product range significantly, introducing innovative devices like drug-eluting balloons. This acquisition plays a vital role in their strategy to improve product quality while enhancing customer engagement.
Increasing Productivity and Capacity
The new logistics center is expected to boost productivity as well as strengthen OrbusNeich's sales and distribution networks both domestically and internationally. By reshaping its storage capabilities, the facility is poised to meet future demands while further streamlining logistics management.
About OrbusNeich Medical Group Holdings Limited
Headquartered in Hong Kong, OrbusNeich is a key player in the medical device sector, focusing on devices used for percutaneous coronary interventions and angioplasty procedures. With a presence in over 70 countries, OrbusNeich is actively expanding into neurovascular interventions and addressing structural heart disease. Their commitment to innovation is reinforced by an extensive portfolio of over 230 patents.
Frequently Asked Questions
What is the primary purpose of the new logistics center?
The logistics center primarily aims to enhance storage abilities and streamline the efficiency of logistics operations for OrbusNeich's products.
Where can we find the new logistics center?
The newly opened logistics center is located in Europe, specifically in Hoevelaken.
In what ways does the new facility promote sustainability?
The facility features advanced digital temperature monitoring, which enhances effective environmental management, aligning with OrbusNeich's sustainability objectives.
What recent acquisition has OrbusNeich completed?
OrbusNeich has recently acquired eucatech AG, which has allowed them to expand their product offerings and bolster their market presence.
Which types of products does OrbusNeich produce?
OrbusNeich specializes in interventional devices designed for procedures such as percutaneous coronary interventions and angioplasty, among others.
